Androgens in the Adolescent

  • Robert Wild
Part of the Clinical Perspective in Obstetrics and Gynecology book series (CPOG)


Adolescence is a time of unrest. Body image and peer interaction are critical to the evolving personality. In a society where the media is constantly promoting certain physical attributes, the adolescent is pressured to look perfect. Obesity, hirsutism, and acne can thwart what is often an unobtainable goal. It therefore behooves all health professionals who treat adolescents to understand abnormal androgen dynamics as found in patients with polycystic ovarian syndrome (PCOS). Intervention may prevent major health problems and can contribute to psychological well-being.


Luteinizing Hormone Polycystic Ovary Polycystic Ovary Syndrome Free Testosterone Luteinizing Hormone Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Merrill J A:The morphology of the prepubertal ovary:Relationship to the polycystic ovary syndrome. South Med J 56:225–31, 1963PubMedCrossRefGoogle Scholar
  2. 2.
    Winter JSD, Faiman C, Reyes FI, et al:Gonadotrophins and steroid hormones in the blood and urine of prepubertal girls and other primates. Clin Endocrinol Metab 7:513–30, 1978PubMedCrossRefGoogle Scholar
  3. 3.
    GoldzieherJW, Green JA:The polycystic ovary.I. Clinical and histologic features. J Clin Endocrinol 22:325–38, 1962CrossRefGoogle Scholar
  4. 4.
    Katz M:Polycystic ovaries. Clin Obstet Gynaecol 8:715 - 31, 1981PubMedGoogle Scholar
  5. 5.
    Yen SSC:The polycystic ovary syndrome. Clin Endocrinol (Oxf) 12:177–207, 1980CrossRefGoogle Scholar
  6. 6.
    Haymond MW, Bussmann Y, Wiest WG:Elevated free testosterone in an obese, hirsute premenarchial girl:effects of norethynodrel and mestranol. Pediatrics 64:609–12, 1979PubMedGoogle Scholar
  7. 7.
    Emans SJ, Grace E, Goldstein DP:Oligomenorrhea in adolescent girls. J Pediatr 97:815–9, 1980PubMedCrossRefGoogle Scholar
  8. 8.
    Moll GW Jr, Rosenfield RL:Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr 102:461–4, 1983PubMedCrossRefGoogle Scholar
  9. 9.
    McKenna TJ, Moore A, Magee F, et al:Amenorrhea with cryptic hyperandrogenemia. J Clin Endocrinol Metab 56:893–6, 1983PubMedCrossRefGoogle Scholar
  10. 10.
    GivensJR:Hirsutism and hyperandrogenism. Adv Intern Med 21:221–47, 1976Google Scholar
  11. 11.
    Stein IF, Levanthal ML:Anenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181–91, 1935Google Scholar
  12. 12.
    Hughesdon PE:Morphology and morpho¬genesis of the Stein-Leventhal ovary and of so- called “hyperthecosis”.Obstet Gynecol Surv 37:59–77, 1982Google Scholar
  13. 13.
    Kim MH, Rosenfield RL, Hosseinian AH, et al:Ovarian hyperandrogenism with normal and abnormal histologic findings of the ovaries. Am J Obstet Gynecol 134:445–52, 1979PubMedGoogle Scholar
  14. 14.
    Kelnar CJH, Brook CGD:A mixed longitud¬inal study of adrenal steroid secretion in childhood and the mechanism of adrenarche. Clin Endocrinol (Oxf) 19:117–29, 1983CrossRefGoogle Scholar
  15. 15.
    Rich BH, Rosenfield RL, Lucky AW, et al:Adrenarche:changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab 52:1129–36, 1981PubMedCrossRefGoogle Scholar
  16. 16.
    Parker LN, Odell WD:Evidence for existence of cortical androgen-stimulating hormone. Am J Physiol 236:616–20, 1979Google Scholar
  17. 17.
    Grumbach MM, Richards GE, Conte FA, et al:Clinical disorders of adrenal function and puberty:an assessment of the role of the adrenal cortex in normal and abnormal puberty in man and evidence for an ACTH-like pituitary adrenal androgen stimulating hormone. In James VHT, Serio M, Giusti G, Martini L (eds):The Endocrine Function of the Human Adrenal Cortex, Serono Symposium 18. London, Academic Press, 1978, p 583Google Scholar
  18. 18.
    Genazzani AR, Facchinetti F, Pintor C, et al:Proopiocortin-related peptide plasma levels throughout prepuberty and puberty. J Clin Endocrinol Metab 57:56–61, 1983PubMedCrossRefGoogle Scholar
  19. 19.
    Wierman M, Beardsworth D, Crawford J, et al:Adrenarche and growth during LHRH agonist (LHRHa) administration. Clin Res 31:681A, 1983Google Scholar
  20. 20.
    Genazzani AR, Pintor C, Corda R:Plasma levels of gonadotropins, prolactin, thyroxine, and adrenal and gonadal steroids in obese prepubertal girls. J Clin Endocrinol Metab 47:974–9, 1978PubMedCrossRefGoogle Scholar
  21. 21.
    McArthur JW, Ingersoll FM, Worcester J:The urinary excretion of interstitial cell and follicle- stimulating hormone activity by women with diseases of the reproductive system. J Clin Endocrinol 18:1202–15, 1958CrossRefGoogle Scholar
  22. 22.
    Yen SSC, Vela P, Rankin J:Inappropriate secretion of follicle stimulating hormone and luteinizing hormone in polycystic ovarian disease. J Clin Endocrinol 30:435–42, 1970CrossRefGoogle Scholar
  23. 23.
    Yen SSC:Chronic anovulation due to inappropriate feedback system. In Yen SSC (ed):Reproductive Endocrinology, Physiology, Pathophysiology, and Clinical Management. Philadelphia, Saunders, 1978, p 297Google Scholar
  24. 24.
    Tanabe K, Gagliano P, Channing CP, et al:Levels of inhibin-F activity and steroids in human follicular fluid from normal women and women with polycystic ovarian disease. J Clin Endocrinol Metab 57:24–31, 1983PubMedCrossRefGoogle Scholar
  25. 25.
    Yen SSC, Chaney C, Judd HL:Functional aberrations of the hypothalamic-pituitary system in polycystic ovary syndrome:a consideration of the pathogenesis. In James VHT, Serio M, Giusti G (eds):The Endocrine Function of the Human Ovary, Serono Symposium 7. London, Academic Press, 1976Google Scholar
  26. 26.
    Ryan KJ, Petro Z, Kaiser J:Steroid formation by isolated and recombined ovarian granulosa and thecal cells. J Clin Endocrinol 28:355–8, 1968CrossRefGoogle Scholar
  27. 27.
    Falck B:Site of production of oestrogen in rat ovary as studied in microtransplants. Acta Physiol Scand 47 (Suppl 163):1–101, 1959Google Scholar
  28. 28.
    Erickson GF:Normal ovarian function. Clin Obstet Gynecol 21:31–52, 1978PubMedCrossRefGoogle Scholar
  29. Weiss G (ed):Reproductive peptides. Semin Reprod Endocrinol 1:26, 1983Google Scholar
  30. Barbieri RL, Ryan KJ, Makris A:Effects of insulin on ovarian steroidogenesis in cultured porcine theca (Abstract #320). Scientific Program and Abstracts for the Thirtieth Annual Meeting of the Society for Gynecologic Investigation, Washington, D.C., March 17–20, 1983, p 172Google Scholar
  31. 31.
    Schreiber JR, Ross GT:Further characterization of a rat ovarian testosterone receptor with evidence for nuclear translocation. Endocrinology 99:590–6, 1976PubMedGoogle Scholar
  32. 32.
    Goldzieher JW, Axelrod LR:Clinical and biochemical features of polycystic ovarian disease. Fertil Steril 14:631–53, 1963PubMedGoogle Scholar
  33. 33.
    Osborn RH, Yannone ME:Plasma androgens in the normal and androgenic female:a review. Obstet Gynecol Surv 26:195–228, 1971CrossRefGoogle Scholar
  34. Bardin CW, Lipsett MB:Testosterone and androstenedione blood production rates in normal women and women with idiopathic hirsutism or polycystic ovaries. J Clin Invest 891–902, 1967Google Scholar
  35. 35.
    Erickson GF, Hsueh AJW, Quigley ME, et al:Functional studies of aromatase activity in human granulosa cells from normal and polycystic ovaries. J Clin Endocrinol Metab 49:514–9, 1979PubMedCrossRefGoogle Scholar
  36. 36.
    Broster LR:Eight years’ experience with the adrenal gland. Arch Surg 34:761–91, 1937Google Scholar
  37. 37.
    Case Records of the Massachusetts General Hospital (case 38172). N Engl J Med 246:667–670, 1952CrossRefGoogle Scholar
  38. Case Records of the Massachusetts General Hospital (case 40072). N Engl J Med 250:296-–300, 1954Google Scholar
  39. 39.
    Goldberg MB:Experience with long-term cortisone therapy in congenital adrenocortical hyperplasia:report of 4 cases. J Clin Endocrinol 14:389–408, 1954CrossRefGoogle Scholar
  40. 40.
    Abu-Haydar N, Laidlaw J, Nusimovich B, et al:Hyperadrenocorticism and the Stein- Leventhal Syndrome. J Clin Endocrinol 14:766, 1954Google Scholar
  41. 41.
    Paschkis RE, Rakoff AE:Clinical endocrinology. In Pincus G, Thimann KV (eds):The Hormones:Physiology, Chemistry and Applications, Vol. 3. New York, Academic Press, 1955, p 859Google Scholar
  42. 42.
    Blackman SS Jr:Concerning function and origin of reticular zone of adrenal cortex:hyperplasia in adrenogenital syndrome. Bull Johns Hopkins Hosp 78:180–217, 1946PubMedGoogle Scholar
  43. 43.
    Jones HW Jr, Jones GES:Gynecological aspects of adrenal hyperplasia and allied disorders. Am J Obstet Gynecol 68:1330–65, 1954PubMedGoogle Scholar
  44. 44.
    Iannaccone A, Gabrilove JL, Sohval AR, et al:The ovaries in Cushing’s syndrome. N Engl J Med 261:775–80, 1959PubMedCrossRefGoogle Scholar
  45. 45.
    Chrousos GP, Loriaux DL, Mann DL, et al:Late-onset 21 -hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. Ann Intern Med 96:143–8, 1982PubMedGoogle Scholar
  46. 46.
    Gabri-love JL, Sharma DC, Dorfman RI:Ad-renocortical 11 -beta-hydroxylase deficiency and virilism first manifest in the adult woman. N Engl J Med 272:1189–94, 1965PubMedCrossRefGoogle Scholar
  47. 47.
    Zachmann M, Tassinari D, Prader A:Clinical and biochemical variability of congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab 56:222–9, 1983PubMedCrossRefGoogle Scholar
  48. 48.
    Sharma DC, Forchielli E, Dorfman RI:Inhibition of enzymatic steroid 11-beta-hydroxyla- tion by androgens. J Biol Chem 238:572–5, 1963Google Scholar
  49. 49.
    Axelrod LR, Goldzieher JW, Ross SD:Concurrent 3-beta-hydroxysteroid dehydrogenase deficiency in adrenal and sclerocystic ovary. Acta Endocrinol 48:392–412, 1965PubMedGoogle Scholar
  50. 50.
    Gallagher TF, Kappas A, Hellman L, et al:Adrenocortical hyperfunction in “idiopathic” hirsutism and the Stein-Leventhal syndrome. J Clin Invest 37:794–9, 1958PubMedCrossRefGoogle Scholar
  51. 51.
    Givens JR, Andersen RN, Ragland JB, et al:Adrenal function in hirsutism. I. Diurnal change and response of plasma adrostenedi- one, testosterone, 17-hydroxyprogesterone, Cortisol, LH and FSH to dexamethasone and 0.5 unit of ACTH. J Clin Endocrinol Metab 40:988 - 1000, 1975PubMedCrossRefGoogle Scholar
  52. 52.
    Lachelin GCL, Barnett M, Hopper BR, et al:Adrenal function in normal women and women with the polycystic ovary syndrome. J Clin Endocrinol Metab 49:892–8, 1979PubMedCrossRefGoogle Scholar
  53. 53.
    Wild RA, Umstot ES, Andersen RN, et al:Adrenal function in hirsutism. II. Effect of an oral contraceptive. J Clin Endocrinol Metab 54:676–81, 1982PubMedCrossRefGoogle Scholar
  54. 54.
    Weibe RH, Morris CV:Effect of an oral contraceptive on adrenal and ovarian androgenic steroids. Obstet Gynecol 63:12–4, 1984Google Scholar
  55. 55.
    Kase N, Kowal J, Perloff W, et al:In vitro production of androgens by a virilizing adrenal adenoma and associated polycystic ovaries. Acta Endocrinol 44:15–9, 1963PubMedGoogle Scholar
  56. 56.
    Plymate SR, Fariss BL, Bassett ML, et al:Obesity and its role in polycystic ovary syndrome. J Clin Endocrinol Metab 52:1246–8, 1981PubMedCrossRefGoogle Scholar
  57. Bates GW, Meeks GR, Gookin KS, et al:Pulsatile serum gonadotropin pattern in obese, anovulatory women (Abstract #134). Scientific Program and Abstracts for the Thirtieth Annual Meeting of the Society for Gynecologic Investigation, Washington, D.C., March 17–20, 1983, p 73Google Scholar
  58. 58.
    Wild RA, Umstot ES, Andersen RN, et al:Androgen parameters and their correlation with body weight in 138 women thought to have hyperandrogenism. Am J Obstet Gynecol 146:602–6, 1983PubMedGoogle Scholar
  59. 59.
    Rowland DL, Perrings TS, Thommes JA:Comparison of androgenic effects on food intake and body weight in adult rats. Physiol Behav 24:205–9, 1980PubMedCrossRefGoogle Scholar
  60. 60.
    Bartuska DG, Eskin BA, Smith EM, et al:Brain damage, hypertrichosis, and polycystic ovaries:clinical evaluation of 7 cases. Am J Obstet Gynecol 99:387–9, 1967PubMedGoogle Scholar
  61. 61.
    Quigley ME, Rakoff JS, Yen SSC:Increased luteinizing hormone sensitivity to dopamine inhibition in polycystic ovary syndrome. J Clin Endocrinol Metab 52:231–4, 1981PubMedCrossRefGoogle Scholar
  62. 62.
    Franks S, Murray MAF, Jequier AM, et al:Incidence and significance of hyperprolactinaemia in women with amenorrhea. Clin Endocrinol (Oxf) 4:597–607, 1975CrossRefGoogle Scholar
  63. 63.
    Futterweit W, Krieger DT:Pituitary tumors associated with hyperprolactinemia and polycystic ovarian disease. Fertil Steril 31:608–13, 1979PubMedGoogle Scholar
  64. 64.
    Anderson DC:Sex-hormone-binding globulin. Clin Endocrinol (Oxf) 3:69–96, 1974CrossRefGoogle Scholar
  65. 65.
    Givens JR, Kerber IJ, Wiser WL, et al:Remission of acanthosis nigricans associated with polycystic ovarian disease and a stromal lute- oma. J Clin Endocrinol Metab 38:347–55, 1974PubMedCrossRefGoogle Scholar
  66. 66.
    Kahn CR, Flier JS, Bar RS, et al:The syndromes of insulin resistance and acanthosis nigricans. N Engl J Med 294:739–45, 1976PubMedCrossRefGoogle Scholar
  67. 67.
    Barnes ND, Palumbo PJ, Hayles AB, et al:Insulin resistance, skin changes, and virilization:a recessively inherited syndrome possibly due to pineal gland dysfunction. Diabetologia 10:285–9, 1974PubMedGoogle Scholar
  68. 68.
    West RJ, Lloyd JK, Turner WML:Familial insulin-resistant diabetes, multiple somatic anomalies, and pineal hyperplasia. Arch Dis Child 50:703–8, 1975PubMedCrossRefGoogle Scholar
  69. 69.
    Huseman CA, Johanson AJ, Varma MM, et al:Congenital lipodystrophy. II. Association with polycystic ovarian disease. J Pediat 95:72–6, 1979PubMedCrossRefGoogle Scholar
  70. 70.
    Burghen GA, Givens JR, Kitabchi AE:Correlation of hyperandrogenism with hyperinsulin- ism in polycystic ovarian disease. J Clin Endocrinol Metab 50:113–6, 1980PubMedCrossRefGoogle Scholar
  71. 71.
    Chang RJ, Nakamura RM, Judd HL, et al:Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57:356–9, 1983PubMedCrossRefGoogle Scholar
  72. 72.
    Wortsman J, Soler NG:Abnormalities of fuel metabolism in the polycystic ovary syndrome. Obstet Gynecol 60:342–5, 1982PubMedGoogle Scholar
  73. Wild et al:Unpublished dataGoogle Scholar
  74. 74.
    Korenman SG:Ban Biery Rep 8:71–85, 1981Google Scholar
  75. 75.
    Marynick SP, Chakmakjian ZH, McCaffree DL, et al:Androgen excess in cystic acne. N Engl J Med 308:981–6, 1983PubMedCrossRefGoogle Scholar
  76. 76.
    Horton R, Tait JF:Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone. J Clin Invest 45:301–13, 1966PubMedCrossRefGoogle Scholar
  77. 77.
    Mowszowicz I, Melanitou E, Doukani A, et al:Androgen binding capacity and 5-alpha-re- ductase activity in pubic skin fibroblasts from hirsute patients. Clin Endocrinol Metab 56:1209–13, 1983CrossRefGoogle Scholar
  78. Baxendale PM, Jacobs HS, James VHT:Salivary testosterone:relationship to unbound plasma testosterone in normal and hyperandrogenic women. Clin Endocrinol (Oxf) 16:595– 603, 1982Google Scholar
  79. 79.
    Pochi PE:Hormones, retinoids, and acne. N Engl J Med 308:1024–5, 1983PubMedCrossRefGoogle Scholar
  80. 80.
    Givens JR, Anderson RN, Wiser WL, et al:Dynamics of suppression and recovery of plasma FSH, LH, androstenedione and testosterone in polycystic ovarian disease using an oral contraceptive. J Clin Endocrinol Metab 38:727–35, 1974PubMedCrossRefGoogle Scholar
  81. 81.
    Talbert LM, Sloan C:The effect of a low dose oral contraceptive on serum testosterone levels in polycystic ovarian disease. Obstet Gynecol 53:694–7, 1979PubMedGoogle Scholar
  82. 82.
    Cumming DC, Yang JC, Rebar RW, et al:Treatment of hirsutism with spironolactone. JAMA 247:1295–8, 1982PubMedCrossRefGoogle Scholar
  83. 83.
    Boyers SP, Buster JE, Marshall JR:Hypothal- amic-pituitary-adrenocortical function during long-term low-dose dexamethasone therapy in hyperandrogenized women. Am J Obstet Gynecol 142:330–9, 1982PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York,Inc 1985

Authors and Affiliations

  • Robert Wild

There are no affiliations available

Personalised recommendations